Your browser doesn't support javascript.
loading
Quality of life independently predicts overall survival in myelofibrosis: Key insights from the COntrolled MyeloFibrosis Study with ORal Janus kinase inhibitor Treatment (COMFORT)-I study.
Kosiorek, Heidi E; Scherber, Robyn M; Geyer, Holly L; Verstovsek, Srdan; Langlais, Blake T; Mazza, Gina L; Gotlib, Jason; Gupta, Vikas; Padrnos, Leslie J; Palmer, Jeanne M; Fleischman, Angela; Mesa, Ruben A; Dueck, Amylou C.
Afiliação
  • Kosiorek HE; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona, USA.
  • Scherber RM; Blueprint Medicines, Cambridge, Massachusetts, USA.
  • Geyer HL; Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA.
  • Verstovsek S; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
  • Langlais BT; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona, USA.
  • Mazza GL; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona, USA.
  • Gotlib J; Stanford University Medical Center, Palo Alto, California, USA.
  • Gupta V; MPN Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Padrnos LJ; Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Palmer JM; Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Fleischman A; Department of Hematology and Oncology, University of California Irvine, Irvine, California, USA.
  • Mesa RA; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, Texas, USA.
  • Dueck AC; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona, USA.
Br J Haematol ; 198(6): 1065-1068, 2022 09.
Article em En | MEDLINE | ID: mdl-35751150

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mielofibrose Primária / Inibidores de Janus Quinases Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mielofibrose Primária / Inibidores de Janus Quinases Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article